Recomendaciones preventivas vasculares. Actualización PAPPS 2024

Recomendaciones preventivas vasculares. Actualización PAPPS 2024

Resumen: Se presentan las recomendaciones del Programa de Actividades Preventivas y Promoción de la Salud (PAPPS) de la Sociedad Española de Medicina de Familia y Comunitaria (semFYC), para la prevención de las enfermedades vasculares (EV). Como novedad en esta edición se incluyen nuevos apartados c...

Full description

Saved in:

Bibliographic Details
Main Authors:	Domingo Orozco-Beltrán, Carlos Brotons-Cuixart, José R. Banegas, Vicente F. Gil-Guillen, Ana M. Cebrián-Cuenca, Enrique Martín-Rioboó, Ariana Jordá-Baldó, Johanna Vicuña, Jorge Navarro-Pérez
Format:	Article
Language:	Spanish
Published:	Elsevier 2024-11-01
Series:	Atención Primaria
Subjects:	Cardiovascular Diseases Diabetes Mellitus Obesity Hypertension Dyslipidemias Primary Health Care
Online Access:	http://www.sciencedirect.com/science/article/pii/S0212656724002658
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Actividades preventivas en el mayor. Actualización PAPPS 2024
by: Rosa Ana García Pliego, et al.
Published: (2024-11-01)

Actividades preventivas en la mujer. Actualización PAPPS 2024
by: Alberto López García-Franco, et al.
Published: (2024-11-01)

Recomendaciones sobre el estilo de vida. Actualización PAPPS 2024
by: Rodrigo Córdoba García, et al.
Published: (2024-11-01)

Prevención de las enfermedades infecciosas. Actualización en vacunas PAPPS 2024
by: Ana Pilar Javierre Miranda, et al.
Published: (2024-11-01)

Recomendaciones de prevención del cáncer. Actualización 2024
by: Cruz Bartolomé-Moreno, et al.
Published: (2024-11-01)

Analyzing lipid profiles and dyslipidemia prevalence in hypertensive patients: a cross-sectional study from primary community health institutions
by: Wenxin Wang, et al.
Published: (2024-12-01)

Correlation between Systolic Blood Pressure and Triglyceride Level in the Uzbekistan Population
by: Bu Yong Kim, et al.
Published: (2021-01-01)

Evaluation of lipid profile in patients with cherry angioma: A case–control study in Iraqi patients
by: Mohammed K. Al-Hattab, et al.
Published: (2024-01-01)

Case series showing the safety and changes in lipid profiles of hemodialysis patients with hypertriglyceridemia after pemafibrate administration
by: Rino Okada, et al.
Published: (2024-12-01)

Relationship between Knowledge and Compliance Using Anti-dyslipidemic Drugs among Hypertensive Patients with Dyslipidemia in Bandung, West Java, Indonesia
by: Sitti Alifa Batasalsabilla, et al.
Published: (2024-06-01)

Screening and Management for Dyslipidemia in Korean Children and Adolescents
by: Jong Seo Yoon, et al.
Published: (2022-07-01)

Bexarotene-induced hypothyroidism and dyslipidemia; a nation-wide study
by: Katsunori Manaka, et al.
Published: (2024-08-01)

Dyslipidemia and Associated Risk Factors among Nigerians with Hypertension
by: Olufisayo Gabriel Ayoade, et al.
Published: (2020-08-01)

Resumen PAPPS Infancia y Adolescencia 2024
by: Olga Cortés Rico, et al.
Published: (2024-11-01)

Influence of pharmacotherapy complexity on compliance with the therapeutic objectives for HIV+ patients on antiretroviral treatment concomitant with therapy for dyslipidemia. INCOFAR Project
by: Rocío Jiménez Galán, et al.
Published: (2016-12-01)

Primary dyslipidemia and cardiometabolic risk: potential of pitavastatin.
by: A. E. Berezin, et al.
Published: (2015-06-01)

Prevalence, Patterns and Factors Associated with Dyslipidemia Among Adult Hypertensive Patients
by: Muktar Hassan Mohamud, et al.
Published: (2024-12-01)

Factors associated with hypercholesterolemia in older adults: A cross‐sectional investigation
by: Maria Clara Alves deOliveira, et al.
Published: (2024-12-01)

Study the relationship between serum lipid profile and bronchial asthma exacerbation
by: Israa S.M.M. Elkordi, et al.
Published: (2024-04-01)

Prevalence of Dyslipidemia and Hypertension in Iraqi Adolescents with Type 1 Diabetes Mellitus
by: Dawood Abdoun, et al.
Published: (2022-12-01)

Temporal changes in lipid concentrations and the prevalence of dyslipidemia among individuals with diabetes, prediabetes, and normal blood glucose from 2011 to 2015
by: Mengjie Zhao, et al.
Published: (2024-11-01)

Primary dyslipidemia and cardiometabolic risk: potential of pitavastatin
by: Berezin A.E., et al.
Published: (2015-06-01)

Exploring the Association between Elevated Liver Enzymes and Diabetes in the PERSIAN Guilan Cohort Study
by: Mohammad Taghi Ashoobi, et al.
Published: (2025-10-01)

Local Shear Stress and Dyslipidemia Interfere with Actin Cyto-Skeleton and Lysosomal Organization Contributing to Vascular Fragility
by: Natalia F. Do Couto, et al.
Published: (2024-10-01)

Continuous and interval aerobic sessions: effects on triglyceride concentrations
by: Eder Santiago, et al.
Published: (2020-12-01)

Beyond identification of familial hypercholesterolemia: Improving downstream visits and treatments in a large health care system
by: Harin Lee, et al.
Published: (2025-03-01)

Mini meta-analysis of anticholinesterase actions of atorvastatin, simvastatin and rosuvastatin, and in silico identification of their protein targets in Mus musculus
by: Fouad Kasim Mohammad, et al.
Published: (2025-06-01)

PCSK9 inhibitors – new era of dyslipidemia treatment - effectiveness in reducing low-density lipoprotein (LDL-C) and cardiovascular risk
by: Radosław Szydłowski, et al.
Published: (2024-12-01)

Nutritional Management of Dyslipidemia in Pakistan: A Systematic Review of International Guidelines and Practices
by: Fizza Najeeb, et al.
Published: (2024-05-01)

Prevalence of dyslipidemia and its influencing factors among adult residents in Hebei province: a cross-sectional survey
by: Qianyu LI, et al.
Published: (2024-11-01)

Prevalence of complications and comorbidities associated with obesity: a health insurance claims analysis
by: Jay P. Bae, et al.
Published: (2025-01-01)

Combined effect of healthy lifestyles and obesity on cardiometabolic risks in Chinese rural adults
by: Hui Fan, et al.
Published: (2025-01-01)

Despite the pandemic: upward trajectories of medication adherence and persistence in patients with dyslipidemia
by: Jieun Jang, et al.
Published: (2024-12-01)

Different levels of lipids, Hb1Ac and cytokines among patients with coronary artery disease
by: Xue Jiang, et al.
Published: (2024-11-01)

Foods elaborated with vegetable by-product effects on blood lipid levels: A systematic review
by: Yolanda E. Pérez-Beltrán, et al.
Published: (2024-12-01)

Efficacy of an intervention to increase therapeutic adherence in patients with secondary prevention for cardiovascular disease: a study protocol for a randomized controlled trial
by: Francisco Manuel Lidón-Muñoz, et al.
Published: (2025-01-01)

Cardiovascular risk factors in relation to hair polycyclic aromatic hydrocarbons in the NESCAV study
by: Feng-Jiao Peng, et al.
Published: (2024-12-01)

Prevalence of Adherence to Anti-hyperlipidemia Medication Among Adults in the Gulf Cooperation Council: A Narrative Scoping Review
by: Hajra H. Amoodi, et al.
Published: (2024-01-01)

Features of dyslipidemia and its influence on endothelium functional state in patients with rheumatoid arthritis and arterial hypertension
by: I. M. Fushtey, et al.
Published: (2021-04-01)

Evaluation of Role of Prognostic Factors on Hearing Outcome in Unilateral Idiopathic Sudden Onset Sensorineural Hearing Loss
by: Namrata Yadav, et al.
Published: (2023-09-01)